ArticleJournal of clinical medicine2024

Incidence and Course of Joint Inflammation Associated with Inflammatory Bowel Disease in Patients Undergoing Treatment with Vedolizumab/Ustekinumab: The VEDUSTAR Study.

Irene Gonzalez Diaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.